/ About Us
Where Science Meets HOPE
HOPE-Neuron Therapeutx is a biotechnology company developing SELanetx™, a novel therapeutic platform designed to treat ALS and related autoimmune neurodegenerative disorders. By harnessing mechanotransduction and controlled hyperoxia, we trigger a natural apoptotic process that reprograms the immune system—without drugs or stem cells.
Backed by an extensive body of published research, leading clinical partnerships, and a growing global IP portfolio, we aim to bring disruptive, scalable healing to patients with ALS, MS, Parkinson’s, and eventually Alzheimer’s.
Backed by an extensive body of published research, leading clinical partnerships, and a growing global IP portfolio, we aim to bring disruptive, scalable healing to patients with ALS, MS, Parkinson’s, and eventually Alzheimer’s.